|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6B
|
|
pubmed:dateCreated |
2009-2-5
|
|
pubmed:abstractText |
A retrospective analysis was carried out on the efficacy and toxicity of the combination of 5-fluorouracil, leucovorin, etoposide and cisplatin (FLEP) in patients with metastatic esophageal cancer treated at our institution.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0250-7005
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4101-4
|
|
pubmed:meshHeading |
pubmed-meshheading:19192667-Aged,
pubmed-meshheading:19192667-Aged, 80 and over,
pubmed-meshheading:19192667-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19192667-Cisplatin,
pubmed-meshheading:19192667-Esophageal Neoplasms,
pubmed-meshheading:19192667-Etoposide,
pubmed-meshheading:19192667-Female,
pubmed-meshheading:19192667-Fluorouracil,
pubmed-meshheading:19192667-Humans,
pubmed-meshheading:19192667-Leucovorin,
pubmed-meshheading:19192667-Male,
pubmed-meshheading:19192667-Middle Aged,
pubmed-meshheading:19192667-Neoplasm Metastasis,
pubmed-meshheading:19192667-Retrospective Studies
|
|
pubmed:articleTitle |
The combination of 5-fluorouracil, leukovorin, etoposide, and cisplatin (FLEP) in patients with metastatic esophageal cancer. A single-institution experience.
|
|
pubmed:affiliation |
Department of Internal Medicine I, Division of Oncology, Medical University of Vienna, A-1090 Vienna, Austria.
|
|
pubmed:publicationType |
Journal Article
|
